RBD-4059

N/A

Report date: 2025/04/11 13:24:55
NME

Base Information

Drug NameRBD-4059
Drug Alias NameRBD-4059RBD4059SR059SR-059
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA
Mechanisms of ActionCoagulation factor XI inhibitorsAsialoglycoprotein receptor modulators
TargetsCoagulation factor XIAsialoglycoprotein receptor
Therapy Area/IndicationsVenous ThrombosisCoronary Artery DiseaseCoronary Disease +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwedenAustraliaEU +[4] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPreclinical
Originator CompaniesSuzhou Ribo Life Science Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesSuzhou Ruibo Biotechnology Co LtdRibocure Pharmaceuticals ABSuzhou Ribo Life Science Co Ltd
Inactive CompaniesN/A
Active IndicationsVenous ThrombosisCoronary Artery DiseaseCoronary Disease +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A